Literature DB >> 25868665

Vascular endothelial growth factors: multitasking functionality in metabolism, health and disease.

Gina A Smith1, Gareth W Fearnley, Michael A Harrison, Darren C Tomlinson, Stephen B Wheatcroft, Sreenivasan Ponnambalam.   

Abstract

Vascular endothelial growth factors (VEGFs) bind to VEGF receptor tyrosine kinases (VEGFRs). The VEGF and VEGFR gene products regulate diverse regulatory pathways in mammalian development, health and disease. The interaction between a particular VEGF and its cognate VEGFR activates multiple signal transduction pathways which regulate different cellular responses including metabolism, gene expression, proliferation, migration, and survival. The family of VEGF isoforms regulate vascular physiology and promote tissue homeostasis. VEGF dysfunction is implicated in major chronic disease states including atherosclerosis, diabetes, and cancer. More recent studies implicate a strong link between response to VEGF and regulation of vascular metabolism. Understanding how this family of multitasking cytokines regulates cell and animal function has implications for treating many different diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25868665     DOI: 10.1007/s10545-015-9838-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  105 in total

1.  Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?

Authors:  Michael Simons
Journal:  J Am Coll Cardiol       Date:  2005-09-06       Impact factor: 24.094

2.  Role of PFKFB3-driven glycolysis in vessel sprouting.

Authors:  Katrien De Bock; Maria Georgiadou; Sandra Schoors; Anna Kuchnio; Brian W Wong; Anna Rita Cantelmo; Annelies Quaegebeur; Bart Ghesquière; Sandra Cauwenberghs; Guy Eelen; Li-Kun Phng; Inge Betz; Bieke Tembuyser; Katleen Brepoels; Jonathan Welti; Ilse Geudens; Inmaculada Segura; Bert Cruys; Franscesco Bifari; Ilaria Decimo; Raquel Blanco; Sabine Wyns; Jeroen Vangindertael; Susana Rocha; Russel T Collins; Sebastian Munck; Dirk Daelemans; Hiromi Imamura; Roland Devlieger; Mark Rider; Paul P Van Veldhoven; Frans Schuit; Ramon Bartrons; Johan Hofkens; Peter Fraisl; Sucheta Telang; Ralph J Deberardinis; Luc Schoonjans; Stefan Vinckier; Jason Chesney; Holger Gerhardt; Mieke Dewerchin; Peter Carmeliet
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

Review 3.  Role of endothelial cell metabolism in vessel sprouting.

Authors:  Katrien De Bock; Maria Georgiadou; Peter Carmeliet
Journal:  Cell Metab       Date:  2013-08-22       Impact factor: 27.287

4.  Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.

Authors:  T Heitzer; T Schlinzig; K Krohn; T Meinertz; T Münzel
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

5.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

6.  A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function.

Authors:  F J Giordano; H P Gerber; S P Williams; N VanBruggen; S Bunting; P Ruiz-Lozano; Y Gu; A K Nath; Y Huang; R Hickey; N Dalton; K L Peterson; J Ross; K R Chien; N Ferrara
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

7.  Interactions of FLT-1 and KDR with phospholipase C gamma: identification of the phosphotyrosine binding sites.

Authors:  S A Cunningham; M P Arrate; T A Brock; M N Waxham
Journal:  Biochem Biophys Res Commun       Date:  1997-11-26       Impact factor: 3.575

8.  Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.

Authors:  F Shalaby; J Rossant; T P Yamaguchi; M Gertsenstein; X F Wu; M L Breitman; A C Schuh
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

9.  Activation of vascular endothelial growth factor receptor-1 sustains angiogenesis and Bcl-2 expression via the phosphatidylinositol 3-kinase pathway in endothelial cells.

Authors:  Jun Cai; Shakil Ahmad; Wen G Jiang; Jianhua Huang; Christopher D Kontos; Mike Boulton; Asif Ahmed
Journal:  Diabetes       Date:  2003-12       Impact factor: 9.461

Review 10.  Why AMD is a disease of ageing and not of development: mechanisms and insights.

Authors:  Kaushal Sharma; Neel Kamal Sharma; Akshay Anand
Journal:  Front Aging Neurosci       Date:  2014-07-10       Impact factor: 5.750

View more
  17 in total

Review 1.  Psoriasis, non-alcoholic fatty liver disease, and cardiovascular disease: Three different diseases on a unique background.

Authors:  Giulia Ganzetti; Anna Campanati; Elisa Molinelli; Annamaria Offidani
Journal:  World J Cardiol       Date:  2016-02-26

2.  Effect of vascular endothelial growth factor and its receptors in adult otitis media with effusion.

Authors:  Mengxiao Ye; Xiping Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-03-27       Impact factor: 2.503

Review 3.  Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.

Authors:  Omar C Logue; Jeremy W D McGowan; Eric M George; Gene L Bidwell
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-09       Impact factor: 2.894

4.  A pig BodyMap transcriptome reveals diverse tissue physiologies and evolutionary dynamics of transcription.

Authors:  Long Jin; Qianzi Tang; Silu Hu; Zhongxu Chen; Xuming Zhou; Bo Zeng; Yuhao Wang; Mengnan He; Yan Li; Lixuan Gui; Linyuan Shen; Keren Long; Jideng Ma; Xun Wang; Zhengli Chen; Yanzhi Jiang; Guoqing Tang; Li Zhu; Fei Liu; Bo Zhang; Zhiqing Huang; Guisen Li; Diyan Li; Vadim N Gladyshev; Jingdong Yin; Yiren Gu; Xuewei Li; Mingzhou Li
Journal:  Nat Commun       Date:  2021-06-17       Impact factor: 14.919

5.  Hyperglycemia induced testicular damage in type 2 diabetes mellitus rats exhibiting microcirculation impairments associated with vascular endothelial growth factor decreased via PI3K/Akt pathway.

Authors:  Lingli Long; Han Qiu; Bing Cai; Ningning Chen; Xiaofang Lu; Shuhui Zheng; Xiaoxin Ye; Yubin Li
Journal:  Oncotarget       Date:  2018-01-04

6.  Connecting genetic risk to disease end points through the human blood plasma proteome.

Authors:  Karsten Suhre; Matthias Arnold; Aditya Mukund Bhagwat; Richard J Cotton; Rudolf Engelke; Johannes Raffler; Hina Sarwath; Gaurav Thareja; Annika Wahl; Robert Kirk DeLisle; Larry Gold; Marija Pezer; Gordan Lauc; Mohammed A El-Din Selim; Dennis O Mook-Kanamori; Eman K Al-Dous; Yasmin A Mohamoud; Joel Malek; Konstantin Strauch; Harald Grallert; Annette Peters; Gabi Kastenmüller; Christian Gieger; Johannes Graumann
Journal:  Nat Commun       Date:  2017-02-27       Impact factor: 14.919

7.  Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice.

Authors:  Mari Merentie; Riina Rissanen; Line Lottonen-Raikaslehto; Jenni Huusko; Erika Gurzeler; Mikko P Turunen; Lari Holappa; Petri Mäkinen; Seppo Ylä-Herttuala
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

8.  Transcriptional profiling reveals extraordinary diversity among skeletal muscle tissues.

Authors:  Erin E Terry; Xiping Zhang; Christy Hoffmann; Laura D Hughes; Scott A Lewis; Jiajia Li; Matthew J Wallace; Lance A Riley; Collin M Douglas; Miguel A Gutierrez-Monreal; Nicholas F Lahens; Ming C Gong; Francisco Andrade; Karyn A Esser; Michael E Hughes
Journal:  Elife       Date:  2018-05-29       Impact factor: 8.140

9.  Tpl2 is required for VEGF-A-stimulated signal transduction and endothelial cell function.

Authors:  Gareth W Fearnley; Izma Abdul-Zani; Antony M Latham; Monica C Hollstein; John E Ladbury; Stephen B Wheatcroft; Adam F Odell; Sreenivasan Ponnambalam
Journal:  Biol Open       Date:  2019-05-17       Impact factor: 2.422

10.  Structure and function of vascular endothelial growth factor and its receptor system.

Authors:  Seong Ah Park; Mi Suk Jeong; Ki-Tae Ha; Se Bok Jang
Journal:  BMB Rep       Date:  2018-02       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.